Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fingolimodum - capsule - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, amylum pregelificatum, natrii laurilsulfas corresp. natrium < 23 mg, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum pro capsula. - multiple sklerose - synthetika

Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - natalizumabum - injektionslösung in einer fertigspritze - natalizumabum 150 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.45 mg. - multiple sklerose - biotechnologika

Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

accord healthcare ag - fingolimodum - capsule rigide - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, amylum pregelificatum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), aqua, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, e 172 (flavum), pro capsula. - multiple sklerose - synthetika

Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - fingolimodum - capsule - fingolimodum 0.25 mg ut fingolimodi hydrochloridum, carmellosum calcicum, natrii stearylis fumaras corresp. natrium 0.0295 mg, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), alcohol butylicus, aqua purificata, propylenglycolum, ethanolum, alcohol isopropylicus, ammoniae solutio 28 per centum, pro capsula. - multiple sklerose - synthetika

Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - fingolimodum - capsule - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, carmellosum calcicum, natrii stearylis fumaras corresp. natrium 0.0295 mg, kapselhülle: gelatina, e 171, e 102 0.0283 mg, e 110 0.0033 mg, drucktinte: lacca, e 172 (nigrum), alcohol butylicus, aqua purificata, propylenglycolum, ethanolum, alcohol isopropylicus, ammoniae solutio 28 per centum, pro capsula. - multiple sklerose - synthetika

Liên Minh Châu Âu - Tiếng Ý - EMA (European Medicines Agency)

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Liên Minh Châu Âu - Tiếng Ý - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Thụy Sĩ - Tiếng Ý - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - fingolimodum - capsule rigide - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, calcii hydrogenophosphas dihydricus, glycinum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Liên Minh Châu Âu - Tiếng Ý - EMA (European Medicines Agency)

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Liên Minh Châu Âu - Tiếng Ý - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).